Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ForSight Vision5, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Written informed consent
At least 18 years of age
Diagnosis in both eyes of either primary open-angle glaucoma (POAG) or ocular hypertension
Best corrected-distance visual acuity score equivalent to 20/80 or better
Stable visual field
Central corneal thickness between 490 - 620 micrometers
IOP for each eye is ≥ 23 mmHg at T=0hr, ≥ 20 mmHg at T=4hr and T=8hr.
Inter-eye IOP difference of ≤ 5.0 mmHg at T=0hr, T=4hr and T=8hr.
IOP for each eye is ≤ 30 mmHg at T=0hr, T=4hr and T=8hr.
You may not be if
Any known contraindication to prostaglandin analog (latanoprost, travoprost, bimatoprost, tafluprost) or timolol
A cardiac or pulmonary condition that in the opinion of the Investigator would contraindicate the use of a topical beta-blocker
Use of any agents known to have a substantial effect on IOP during planned study period (e.g. beta-blockers)
Cup-to-disc ratio of greater than 0.8
Significant risk of angle closure due to pupil dilation, defined as a Shaffer classification of less than Grade 2 based on gonioscopy
Ocular, orbital, and/or eyelid surgery of any type within the past six (6) months from screening date
Laser surgery for glaucoma / ocular hypertension on one (1) or both eyes within the last six (6) months
Past history of any incisional surgery for glaucoma at any time
Past history of corneal refractive surgery
Corneal abnormalities that would interfere with accurate IOP readings with an applanation tonometer
Current participation in an investigational drug or device study or participation in such a study within 7 days of Screening
Inability to adequately evaluate the retina
Subjects who will require contact lens use during the study period.
Subjects who currently have punctal occlusion
Pregnant, lactating or of child-bearing potential and not using a medically acceptable form of birth control
Clareo Health | A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension
